comparemela.com

Latest Breaking News On - Pyxis oncology daily - Page 3 : comparemela.com

HC Wainwright Increases Pyxis Oncology (NASDAQ:PYXS) Price Target to $7.00

Pyxis Oncology (NASDAQ:PYXS – Free Report) had its price target upped by HC Wainwright from $4.00 to $7.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other equities research analysts have also issued reports about the company. BTIG Research began coverage […]

Leerink-partnrs
Blackrock-inc
Vanguard-group-inc
York-mellon-corp
Citigroup-inc
Pyxis-oncology-inc
Pyxis-oncology
Free-report
Oncology-trading-down
New-york-mellon-corp
State-street-corp
Street-corp

HC Wainwright Boosts Pyxis Oncology (NASDAQ:PYXS) Price Target to $7.00

Pyxis Oncology (NASDAQ:PYXS – Free Report) had its target price boosted by HC Wainwright from $4.00 to $7.00 in a report issued on Friday morning, Benzinga reports. They currently have a buy rating on the stock. Several other research firms also recently commented on PYXS. BTIG Research started coverage on Pyxis Oncology in a report […]

Leerink-partnrs
Prelude-capital-management
Commonwealth-equity-services
Pyxis-oncology-company-profile
Pyxis-oncology-inc
Acadian-asset-management
Pyxis-oncology
Free-report
Capital-management
Asset-management
Investment-advisers
Equity-services

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Recommendation of "Buy" by Brokerages

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Recommendation of "Buy" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
William-blair
Harvest-investment-services
Prelude-capital-management
Nasdaq
Pyxis-oncology-company-profile
Commonwealth-equity-services
Pyxis-oncology-inc
Pyxis-oncology
Get-free-report
Investment-advisers
Equity-services

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Recommendation of "Buy" by Analysts

Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has earned an average rating of “Buy” from the eight research firms that are presently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the […]

William-blair
Leerink-partnrs
Prelude-capital-management
Nasdaq
Harvest-investment-services
Pyxis-oncology-inc
Commonwealth-equity-services
Pyxis-oncology
Get-free-report
Marketbeat-ratings
Investment-advisers
Equity-services

Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.25

Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.25
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
William-blair
Citigroup-inc
Pyxis-oncology-inc
Nasdaq
Renaissance-technologies
Pyxis-oncology
Get-free-report
Capital-management
Point-capital-management
Get-free
Pyxis-oncology-daily
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.